MedPath

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Phase 3
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Drug: LHRH agonist
Procedure: surgery
Registration Number
NCT00430183
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as goserelin and leuprolide, may stop the adrenal glands from making androgens. Giving docetaxel and leuprolide or goserelin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. It is not yet known whether giving docetaxel and leuprolide or goserelin before surgery is more effective than surgery alone in treating patients with prostate cancer.

PURPOSE: This randomized phase III trial is studying docetaxel and leuprolide or goserelin to see how well they work when given before surgery compared with surgery alone in treating patients with high-risk localized prostate cancer.

Detailed Description

This randomized trial tests whether the addition of chemohormonal therapy improves PSA-progression free survival in patients with high risk, clinically-localized prostate cancer. The neoadjuvant approach is taken since there appears to be a higher acceptance rate in the prostate population for this type of therapy and several phase II trials have demonstrated its safety. Multiple chemotherapeutic therapies have shown efficacy in advanced prostate cancer and docetaxel has become the community standard. Many high risk patients are initiated on LHRH agonists at or near the time of diagnosis of their prostate cancer. In order to allow the inclusion of these patients in the protocol, enhanced enrollment and maintain compliance with therapy, up to 3 months of androgen deprivation therapy prior to enrollment will be permitted. This study will therefore be able to test the hypothesis that targeting both androgen-sensitive and chemotherapy- sensitive prostate cancer cells will improve outcomes in these high-risk patients.

OUTLINE: This is a multicenter, randomized study. Patients are stratified according to nomogram-predicted biochemical progression-free survival at 5 years (0-20.9% vs 21-39.9% vs 40-59.9% vs ≥ 60%) and androgen-deprivation therapy prior to randomization ≤ 4 months (no vs yes). Patients are randomized to 1 of 2 treatment arms. Please see the Arms sections for more details.

The primary and secondary objectives are described below.

Primary:

- To determine whether treatment with neoadjuvant docetaxel and androgen deprivation therapy prior to radical prostatectomy will increase the rate of 3-year biochemical progression-free survival (bPFS) compared to treatment with immediate radical prostatectomy alone for high-risk prostate cancer patients.

Secondary:

* To compare the 5-year bPFS rate, bPFS, disease progression, disease-free survival, and overall survival of patients randomized to the two arms of this trial

* To determine the safety and tolerability of neoadjuvant docetaxel and androgen deprivation therapy prior to surgery for high-risk patients undergoing radical prostatectomy

* To compare the impact of neoadjuvant docetaxel and androgen deprivation therapy on time to clinically apparent local disease recurrence and metastatic disease in high-risk patients undergoing radical prostatectomy for clinically localized prostate cancer

* To compare the impact of neoadjuvant docetaxel and androgen deprivation therapy relative to RP on pathologic tumor stage, frequency of lymph node metastases and positive margin rates for high-risk patients undergoing radical prostatectomy for clinically localized prostate cancer

* To determine if changes in serum testosterone levels will predict bPFS

* To determine prospectively whether PSA doubling time (PSADT) is a surrogate endpoint for time to clinical metastases and overall survival

Patients are followed up to 15 years post-randomization.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
788
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A: docetaxel + LHRH agonist + surgical interventionLHRH agonistPatients receive six cycles of docetaxel administered every 3 weeks combined with 18-24 weeks of androgen deprivation therapy. During each cycle of chemotherapy, all patients should undergo premedication with dexamethasone 8 mg orally prior to docetaxel. Dexamethasone may also be given intravenously according to institutional guidelines. Patients will also receive androgen deprivation for 18-24 weeks of an LHRH agonist (eg, leuprolide acetate, goserelin acetate). Additional premedication and antiemetics may be given at the physician's discretion and as defined by the protocol. Patients will undergo standard surgical intervention. The surgical procedures will be performed within 60 days of the completion of neoadjuvant therapy. Patients are allowed to receive adjuvant external beam radiation at the discretion of the treating physician and as defined per the protocol. It must be initiated within 6 months of the date of surgery.
Arm A: docetaxel + LHRH agonist + surgical interventionsurgeryPatients receive six cycles of docetaxel administered every 3 weeks combined with 18-24 weeks of androgen deprivation therapy. During each cycle of chemotherapy, all patients should undergo premedication with dexamethasone 8 mg orally prior to docetaxel. Dexamethasone may also be given intravenously according to institutional guidelines. Patients will also receive androgen deprivation for 18-24 weeks of an LHRH agonist (eg, leuprolide acetate, goserelin acetate). Additional premedication and antiemetics may be given at the physician's discretion and as defined by the protocol. Patients will undergo standard surgical intervention. The surgical procedures will be performed within 60 days of the completion of neoadjuvant therapy. Patients are allowed to receive adjuvant external beam radiation at the discretion of the treating physician and as defined per the protocol. It must be initiated within 6 months of the date of surgery.
Arm B: surgical interventionsurgeryAll patients undergo standard surgical intervention. The surgical procedures will be performed within 60 days of randomization. Patients are allowed to receive adjuvant external beam radiation at the discretion of the treating physician and as defined per the protocol. Adjuvant radiation must be initiated within 6 months of the date of surgery.
Arm A: docetaxel + LHRH agonist + surgical interventiondocetaxelPatients receive six cycles of docetaxel administered every 3 weeks combined with 18-24 weeks of androgen deprivation therapy. During each cycle of chemotherapy, all patients should undergo premedication with dexamethasone 8 mg orally prior to docetaxel. Dexamethasone may also be given intravenously according to institutional guidelines. Patients will also receive androgen deprivation for 18-24 weeks of an LHRH agonist (eg, leuprolide acetate, goserelin acetate). Additional premedication and antiemetics may be given at the physician's discretion and as defined by the protocol. Patients will undergo standard surgical intervention. The surgical procedures will be performed within 60 days of the completion of neoadjuvant therapy. Patients are allowed to receive adjuvant external beam radiation at the discretion of the treating physician and as defined per the protocol. It must be initiated within 6 months of the date of surgery.
Primary Outcome Measures
NameTimeMethod
Proportion of Biochemical Progression-Free Survival (bPFS Proportion) at 3 YearsUp to 3 years

Proportion of participants surviving 3 years from randomization without biochemical progression or death. bPFS was defined as the time from randomization to the date of the first documented biochemical progression or death. Progression will be defined as having experienced either of the following: a serum PSA level \> 0.2 ng/mL that increases on 2 consecutive occasions each of which is at least 3 months apart or death occurs. The time of biochemical failure is measured from the date of randomization to the date of the first PSA level \> 0.2 ng/mL.

Secondary Outcome Measures
NameTimeMethod
5-year bPFS Rate5 years

Proportion of participants surviving 5 years from randomization without biochemical progression or death.

Unacceptable Toxicity (Grade 3 or Higher Toxicity)Up to 15 years post-randomization
Overall Survival (The Date of Randomization to the Time of Death Due to Prostate Cancer.)Up to 15 years post-randomization
Time to Clinical Local Recurrence (The Time From Randomization to the First Biopsy-proven Recurrence in the Prostatic Bed or New Mass.)Up to 15 years post-randomization
Time to Metastatic Disease Progression (The Date of Randomization to Date of Evidence of Systemic Disease on Bone Scan or Cross Sectional Imaging.)Up to 15 years post-randomization
Prostate Cancer-specific-free Survival (The Time From Randomization to the Time of Death Due to Prostate Cancer.)Up to 15 years post-randomization
Disease ProgressionUp to 15 years post-randomization

Trial Locations

Locations (226)

Michiana Hematology-Oncology, PC - Elkhart

🇺🇸

Elkhart, Indiana, United States

Munson Medical Center

🇺🇸

Traverse City, Michigan, United States

Mercy and Unity Cancer Center at Mercy Hospital

🇺🇸

Coon Rapids, Minnesota, United States

AnMed Health Cancer Center

🇺🇸

Anderson, South Carolina, United States

Sutter Solano Medical Center

🇺🇸

Vallejo, California, United States

Central Dupage Cancer Center

🇺🇸

Warrenville, Illinois, United States

Elkhart General Hospital

🇺🇸

Elkhart, Indiana, United States

Maine Center for Cancer Medicine and Blood Disorders - Scarborough

🇺🇸

Scarborough, Maine, United States

Minnesota Oncology - Woodbury

🇺🇸

Woodbury, Minnesota, United States

Great Falls Clinic - Main Facility

🇺🇸

Great Falls, Montana, United States

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center - Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

Fox Chase Virtua Health Cancer Program at Virtua West Jersey

🇺🇸

Voorhees, New Jersey, United States

Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center

🇺🇸

Kingsport, Tennessee, United States

Alta Bates Summit Comprehensive Cancer Center

🇺🇸

Berkeley, California, United States

Providence Cancer Center

🇺🇸

Anchorage, Alaska, United States

USC/Norris Comprehensive Cancer Center and Hospital

🇺🇸

Los Angeles, California, United States

Tahoe Forest Cancer Center

🇺🇸

Truckee, California, United States

Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital

🇺🇸

Fairbanks, Alaska, United States

Veterans Affairs Medical Center - Hines

🇺🇸

Hines, Illinois, United States

Rutherford Hospital

🇺🇸

Rutherfordton, North Carolina, United States

Presbyterian Cancer Center at Presbyterian Hospital

🇺🇸

Charlotte, North Carolina, United States

Wayne Memorial Hospital, Incorporated

🇺🇸

Goldsboro, North Carolina, United States

Kinston Medical Specialists

🇺🇸

Kinston, North Carolina, United States

Fletcher Allen Health Care - University Health Center Campus

🇺🇸

Burlington, Vermont, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

St. Clare Hospital

🇺🇸

Tacoma, Washington, United States

St. Francis Cancer Center at St. Francis Medical Center

🇺🇸

Shakopee, Minnesota, United States

New York Weill Cornell Cancer Center at Cornell University

🇺🇸

New York, New York, United States

Seattle Cancer Care Alliance at EvergreenHealth

🇺🇸

Kirkland, Washington, United States

Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Rockwood Clinic Cancer Treatment Center

🇺🇸

Spokane, Washington, United States

Franciscan Cancer Center at St. Joseph Medical Center

🇺🇸

Tacoma, Washington, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

Veterans Affairs Medical Center - Syracuse

🇺🇸

Syracuse, New York, United States

Iredell Memorial Hospital

🇺🇸

Statesville, North Carolina, United States

Good Samaritan Cancer Center

🇺🇸

Puyallup, Washington, United States

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

Madigan Army Medical Center - Tacoma

🇺🇸

Tacoma, Washington, United States

Somerset Medical Center

🇺🇸

Somerville, New Jersey, United States

Edwards Comprehensive Cancer Center at Cabell Huntington Hospital

🇺🇸

Huntington, West Virginia, United States

Tom Baker Cancer Centre - Calgary

🇨🇦

Calgary, Alberta, Canada

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center

🇺🇸

Spartanburg, South Carolina, United States

Carolinas Medical Center - Union

🇺🇸

Monroe, North Carolina, United States

Cleveland Regional Medical Center

🇺🇸

Shelby, North Carolina, United States

Southwest Virginia Regional Cancer Center at Wellmonth Health

🇺🇸

Norton, Virginia, United States

Mountainview Medical

🇺🇸

Berlin, Vermont, United States

St. Francis Hospital

🇺🇸

Federal Way, Washington, United States

Providence St. Peter Hospital Regional Cancer Center

🇺🇸

Olympia, Washington, United States

Gundersen Lutheran Center for Cancer and Blood

🇺🇸

La Crosse, Wisconsin, United States

West Virginia University Health Sciences Center - Charleston

🇺🇸

Charleston, West Virginia, United States

University of Chicago Cancer Research Center

🇺🇸

Chicago, Illinois, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

Virginia Mason Medical Center

🇺🇸

Seattle, Washington, United States

Pacific Medical Center

🇺🇸

Seattle, Washington, United States

University Medical Center of Southern Nevada

🇺🇸

Las Vegas, Nevada, United States

Naval Medical Center - San Diego

🇺🇸

San Diego, California, United States

California Pacific Medical Center - Pacific Campus

🇺🇸

San Francisco, California, United States

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Hennepin County Medical Center - Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

Duke Cancer Institute

🇺🇸

Durham, North Carolina, United States

Rocky Mountain Oncology

🇺🇸

Casper, Wyoming, United States

Welch Cancer Center at Sheridan Memorial Hospital

🇺🇸

Sheridan, Wyoming, United States

MBCCOP - Meharry Medical College - Nashville

🇺🇸

Nashville, Tennessee, United States

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

Montana Cancer Specialists at Montana Cancer Center

🇺🇸

Missoula, Montana, United States

Kalispell Regional Medical Center

🇺🇸

Kalispell, Montana, United States

St. Vincent Healthcare Cancer Care Services

🇺🇸

Billings, Montana, United States

Bozeman Deaconess Cancer Center

🇺🇸

Bozeman, Montana, United States

St. James Healthcare Cancer Care

🇺🇸

Butte, Montana, United States

Oklahoma University Cancer Institute

🇺🇸

Oklahoma City, Oklahoma, United States

Denver Health Medical Center

🇺🇸

Denver, Colorado, United States

Veterans Affairs Medical Center - Denver

🇺🇸

Denver, Colorado, United States

Josephine Ford Cancer Center at Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Kansas City Cancer Centers - East

🇺🇸

Lee's Summit, Missouri, United States

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis

🇺🇸

Saint Louis, Missouri, United States

University of California Davis Cancer Center

🇺🇸

Sacramento, California, United States

University of Colorado Cancer Center at UC Health Sciences Center

🇺🇸

Aurora, Colorado, United States

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida

🇺🇸

Tampa, Florida, United States

Saint Joseph Mercy Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

CCOP - Missouri Valley Cancer Consortium

🇺🇸

Omaha, Nebraska, United States

Immanuel Medical Center

🇺🇸

Omaha, Nebraska, United States

Creighton University Medical Center

🇺🇸

Omaha, Nebraska, United States

Methodist Estabrook Cancer Center

🇺🇸

Omaha, Nebraska, United States

Lakeside Hospital

🇺🇸

Omaha, Nebraska, United States

Forsyth Regional Cancer Center at Forsyth Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

Peninsula Medical Center

🇺🇸

Burlingame, California, United States

Sutter Health - Western Division Cancer Research Group

🇺🇸

Novato, California, United States

Sutter Pacific Medical Foundation

🇺🇸

Santa Rosa, California, United States

Shaw Regional Cancer Center

🇺🇸

Edwards, Colorado, United States

Valley View Hospital Cancer Center

🇺🇸

Glenwood Springs, Colorado, United States

Montrose Memorial Hospital Cancer Center

🇺🇸

Montrose, Colorado, United States

Helen and Harry Gray Cancer Center at Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Veterans Affairs Medical Center - West Haven

🇺🇸

West Haven, Connecticut, United States

Eastern Connecticut Hematology and Oncology Associates

🇺🇸

Norwich, Connecticut, United States

CCOP - Christiana Care Health Services

🇺🇸

Newark, Delaware, United States

Tunnell Cancer Center at Beebe Medical Center

🇺🇸

Lewes, Delaware, United States

Ella Milbank Foshay Cancer Center at Jupiter Medical Center

🇺🇸

Jupiter, Florida, United States

CCOP - Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital

🇺🇸

Fort Lauderdale, Florida, United States

Cleveland Clinic Florida - Weston

🇺🇸

Weston, Florida, United States

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

🇺🇸

Hartford, Connecticut, United States

Kapiolani Medical Center at Pali Momi

🇺🇸

'Aiea, Hawaii, United States

Castle Medical Center

🇺🇸

Kailua, Hawaii, United States

Maui Memorial Medical Center

🇺🇸

Wailuku, Hawaii, United States

Kauai Medical Clinic

🇺🇸

Lihue, Hawaii, United States

Idaho Urologic Institute, PA

🇺🇸

Meridian, Idaho, United States

Pacific Cancer Institute - Maui

🇺🇸

Wailuku, Hawaii, United States

Louis A. Weiss Memorial Hospital

🇺🇸

Chicago, Illinois, United States

Decatur Memorial Hospital Cancer Care Institute

🇺🇸

Decatur, Illinois, United States

Delnor Hospital - Geneva

🇺🇸

Geneva, Illinois, United States

Cardinal Bernardin Cancer Center at Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

Regional Cancer Center at Memorial Medical Center

🇺🇸

Springfield, Illinois, United States

Elkhart Clinic, LLC

🇺🇸

Elkhart, Indiana, United States

Howard Community Hospital

🇺🇸

Kokomo, Indiana, United States

Center for Cancer Therapy at LaPorte Hospital and Health Services

🇺🇸

La Porte, Indiana, United States

Michiana Hematology-Oncology, PC - South Bend

🇺🇸

Mishawaka, Indiana, United States

CCOP - Northern Indiana CR Consortium

🇺🇸

South Bend, Indiana, United States

Michiana Hematology Oncology PC - Plymouth

🇺🇸

Plymouth, Indiana, United States

Saint Joseph Regional Medical Center

🇺🇸

Mishawaka, Indiana, United States

Michiana Hematology Oncology PC - La Porte

🇺🇸

Westville, Indiana, United States

Memorial Hospital of South Bend

🇺🇸

South Bend, Indiana, United States

Hematology Oncology Associates of the Quad Cities

🇺🇸

Bettendorf, Iowa, United States

Holden Comprehensive Cancer Center at University of Iowa

🇺🇸

Iowa City, Iowa, United States

Genesis Regional Cancer Center at Genesis Medical Center

🇺🇸

Davenport, Iowa, United States

St. Rose Ambulatory and Surgery Center

🇺🇸

Great Bend, Kansas, United States

Hays Medical Center

🇺🇸

Hays, Kansas, United States

Hutchinson Hospital Corporation

🇺🇸

Hutchinson, Kansas, United States

Kansas City Cancer Centers - West

🇺🇸

Kansas City, Kansas, United States

Mount Carmel Regional Cancer Center

🇺🇸

Pittsburg, Kansas, United States

Kansas City Cancer Centers - Southwest

🇺🇸

Overland Park, Kansas, United States

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

St. Francis Comprehensive Cancer Center

🇺🇸

Topeka, Kansas, United States

Kansas City Cancer Center - Shawnee Mission

🇺🇸

Shawnee Mission, Kansas, United States

Pennington Cancer Center at Baton Rouge General

🇺🇸

Baton Rouge, Louisiana, United States

Tammy Walker Cancer Center at Salina Regional Health Center

🇺🇸

Salina, Kansas, United States

Mary Bird Perkins Cancer Center - Baton Rouge

🇺🇸

Baton Rouge, Louisiana, United States

Berkshire Hematology Oncology, PC

🇺🇸

Pittsfield, Massachusetts, United States

Peninsula Regional Medical Center

🇺🇸

Salisbury, Maryland, United States

Union Hospital of Cecil County

🇺🇸

Elkton, Maryland, United States

Tufts Medical Center Cancer Center

🇺🇸

Boston, Massachusetts, United States

CCOP - Michigan Cancer Research Consortium

🇺🇸

Ann Arbor, Michigan, United States

Oakwood Cancer Center at Oakwood Hospital and Medical Center

🇺🇸

Dearborn, Michigan, United States

Mecosta County Medical Center

🇺🇸

Big Rapids, Michigan, United States

Genesys Hurley Cancer Institute

🇺🇸

Flint, Michigan, United States

CCOP - Grand Rapids

🇺🇸

Grand Rapids, Michigan, United States

Hurley Medical Center

🇺🇸

Flint, Michigan, United States

Lacks Cancer Center at Saint Mary's Health Care

🇺🇸

Grand Rapids, Michigan, United States

Van Elslander Cancer Center at St. John Hospital and Medical Center

🇺🇸

Grosse Pointe Woods, Michigan, United States

Foote Memorial Hospital

🇺🇸

Jackson, Michigan, United States

St. Mary Mercy Hospital

🇺🇸

Livonia, Michigan, United States

Sparrow Regional Cancer Center

🇺🇸

Lansing, Michigan, United States

Mercy General Health Partners

🇺🇸

Muskegon, Michigan, United States

St. Joseph Mercy Oakland

🇺🇸

Pontiac, Michigan, United States

Spectrum Health Reed City Hospital

🇺🇸

Reed City, Michigan, United States

Seton Cancer Institute at Saint Mary's - Saginaw

🇺🇸

Saginaw, Michigan, United States

Lakeside Cancer Specialists, PLLC

🇺🇸

Saint Joseph, Michigan, United States

Mercy Regional Cancer Center at Mercy Hospital

🇺🇸

Port Huron, Michigan, United States

Fairview Ridges Hospital

🇺🇸

Burnsville, Minnesota, United States

Lakeland Regional Cancer Care Center - St. Joseph

🇺🇸

Saint Joseph, Michigan, United States

St. John Macomb Hospital

🇺🇸

Warren, Michigan, United States

Mercy and Unity Cancer Center at Unity Hospital

🇺🇸

Fridley, Minnesota, United States

Fairview Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Hutchinson Area Health Care

🇺🇸

Hutchinson, Minnesota, United States

HealthEast Cancer Care at St. John's Hospital

🇺🇸

Maplewood, Minnesota, United States

New Ulm Medical Center

🇺🇸

New Ulm, Minnesota, United States

Humphrey Cancer Center at North Memorial Outpatient Center

🇺🇸

Robbinsdale, Minnesota, United States

Minnesota Oncology - Maplewood

🇺🇸

Maplewood, Minnesota, United States

Masonic Cancer Center at University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

CentraCare Clinic - River Campus

🇺🇸

Saint Cloud, Minnesota, United States

CCOP - Metro-Minnesota

🇺🇸

Saint Louis Park, Minnesota, United States

Regions Hospital Cancer Care Center

🇺🇸

Saint Paul, Minnesota, United States

Coborn Cancer Center

🇺🇸

Saint Cloud, Minnesota, United States

Park Nicollet Cancer Center

🇺🇸

Saint Louis Park, Minnesota, United States

United Hospital

🇺🇸

Saint Paul, Minnesota, United States

Lakeview Hospital

🇺🇸

Stillwater, Minnesota, United States

Ridgeview Medical Center

🇺🇸

Waconia, Minnesota, United States

Willmar Cancer Center at Rice Memorial Hospital

🇺🇸

Willmar, Minnesota, United States

University of Mississippi Cancer Clinic

🇺🇸

Jackson, Mississippi, United States

Hematology-Oncology Centers of the Northern Rockies - Billings

🇺🇸

Billings, Montana, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Billings Clinic

🇺🇸

Billings, Montana, United States

Benefis Healthcare - Sletten Cancer Institute

🇺🇸

Great Falls, Montana, United States

St. Peter's Hospital

🇺🇸

Helena, Montana, United States

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

🇺🇸

Missoula, Montana, United States

CCOP - Nevada Cancer Research Foundation

🇺🇸

Las Vegas, Nevada, United States

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care

🇺🇸

Concord, New Hampshire, United States

New Hampshire Oncology - Hematology, PA - Hooksett

🇺🇸

Hooksett, New Hampshire, United States

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton

🇺🇸

Marlton, New Jersey, United States

Carol G. Simon Cancer Center at Morristown Memorial Hospital

🇺🇸

Morristown, New Jersey, United States

Frederick R. and Betty M. Smith Cancer Treatment Center

🇺🇸

Sparta, New Jersey, United States

Overlook Hospital

🇺🇸

Summit, New Jersey, United States

SUNY Upstate Medical University Hospital

🇺🇸

Syracuse, New York, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

Wake Forest University Comprehensive Cancer Center

🇺🇸

Winston-Salem, North Carolina, United States

St. Rita's Medical Center

🇺🇸

Lima, Ohio, United States

Kaiser Permanente Health Care - Portland

🇺🇸

Portland, Oregon, United States

Bay Area Hospital

🇺🇸

Coos Bay, Oregon, United States

Mercy Fitzgerald Hospital

🇺🇸

Darby, Pennsylvania, United States

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

Lynchburg Hematology-Oncology Clinic

🇺🇸

Lynchburg, Virginia, United States

Providence Centralia Hospital

🇺🇸

Centralia, Washington, United States

Cascade Cancer Center at Evergreen Hospital Medical Center

🇺🇸

Kirkland, Washington, United States

MultiCare Regional Cancer Center at Tacoma General Hospital

🇺🇸

Tacoma, Washington, United States

Hopital Notre-Dame du CHUM

🇨🇦

Montreal, Quebec, Canada

Florida Hospital Cancer Institute at Florida Hospital Orlando

🇺🇸

Orlando, Florida, United States

Yale Cancer Center

🇺🇸

New Haven, Connecticut, United States

OnCare Hawaii, Incorporated - Lusitana

🇺🇸

Honolulu, Hawaii, United States

Queen's Cancer Institute at Queen's Medical Center

🇺🇸

Honolulu, Hawaii, United States

Straub Clinic and Hospital, Incorporated

🇺🇸

Honolulu, Hawaii, United States

Hawaii Medical Center - East

🇺🇸

Honolulu, Hawaii, United States

OnCare Hawaii, Incorporated - Kuakini

🇺🇸

Honolulu, Hawaii, United States

Veterans Affairs Medical Center - Kansas City

🇺🇸

Kansas City, Missouri, United States

Kansas City Cancer Centers - South

🇺🇸

Kansas City, Missouri, United States

Kansas City Cancer Centers - North

🇺🇸

Kansas City, Missouri, United States

Kapiolani Medical Center for Women and Children

🇺🇸

Honolulu, Hawaii, United States

MBCCOP - LSU Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

Medical Center of Louisiana - New Orleans

🇺🇸

New Orleans, Louisiana, United States

Truman Medical Center - Hospital Hill

🇺🇸

Kansas City, Missouri, United States

Roper St. Francis Cancer Center at Roper Hospital

🇺🇸

Charleston, South Carolina, United States

Hematology Oncology Associates, PC

🇺🇸

Albuquerque, New Mexico, United States

Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital

🇺🇸

Albuquerque, New Mexico, United States

University of New Mexico Cancer Center

🇺🇸

Albuquerque, New Mexico, United States

London Regional Cancer Program at London Health Sciences Centre

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath